 |
Visit www.actavis.dk to learn more about Actavis.>
Actavis Group is among the five leading generic pharmaceutical companies in the world, with 11,000 employees in close to 40 countries. Founded in 1956, the Group now operates across five continents and has its headquarters in Iceland.
Today Actavis has modern development and manufacturing facilities in Europe, the US and Asia. The plants produce a variety of medicines in different formulations including tablets, capsules, injectables, suppositories, sprays, steriles, powders, oral liquids and semi solids. Actavis has one of the broadest portfolios in the generic sector with over 650 products on the market, in addition to over 350 products in the development pipeline and in registration, enabling Actavis to provide its customers with a wide range of affordable high quality pharmaceuticals.
|
|
 |
|
|
